SEC Form 4 · accession 0001487371-18-000029
GenMark Diagnostics, Inc. · GNMK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Anne Williams
Officer — SVP, Human Resources
Period of report
Feb 20, 2018
Accepted (ET)
Feb 21, 2018 · 6:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001487371
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2018 | S | 2,177 | $4.37 | D | 149,342 | D | |
| Common StockF3 | Feb 21, 2018 | S | 2,970 | $4.42 | D | 146,372 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units.
- F2This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by reporting person on 8/16/2017.
- F3The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $4.38 to $4.46 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.